CYP19A1 and breast cancer: Evidence from studies in humans suggests several possible mechanisms for green tea catechins, including antiproliferative effects, demonstrated in a study of its effects on tumor Ki-67 in breast cancer tissue (86), and modest aromatase inhibition, but with no reports of interaction between green tea catechins and aromatase inhibitor drugs (87).